OS Therapies OSTX
NYSE OSTX
$1.63 +0.02 (+1.24%)
As of: Oct 2, 2026 · 11:21 AM EDT

OS Therapies (OSTX) Short-Term Debt issuances (2024)

Updated

OS Therapies (OSTX) reported Short-Term Debt issuances of $250,000 for FY2024.

Analysis

OS Therapies (OSTX) Short-Term Debt issuances (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 707.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 OS Therapies 7.73 Mn 7.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 150,000.00
Mar 31, 2024 100,000.00
API Access

OS Therapies Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=OSTX&period=max&api_key=YOUR_API_KEY